New Jersey, June 13, 2022 - Freyr announced that a leading global Bio-pharmaceutical company selected Freyr IMPACT as its global Regulatory Intelligence (RI) solution to transform their current Regulatory Intelligence ecosystem.
Imagine if a major web-based collaborative platform application that you use currently does not integrate with any other systems and requires a magnificent amount of manual intervention at this age! Wouldn’t it be challenging? The Biopharma leader had similar challenges, as their application was at an end-of-life position and was not capable of capturing global Health Authority requirements in real-time. In addition, the customer wanted to replace multiple applications and file-based data management tools with a centralized platform.
Consequently, the selection of Freyr IMPACT came natural for the Pharma company for automated data capturing, cleansing, and managing changing global Regulatory requirements, including policies, guidance documents, etc. On the other hand, it was to enable critical decision-making processes and introduce innovative technologies, including robotic process automation/AI/ML.
With a centralized repository, global dashboard, actionable insights, SME synopsis, and recommendations, Freyr IMPACT is all set to transform the customer’s Regulatory Intelligence ecosystem, and the scope of migrating 2.9 Mn+ records stand as a key highlight of the project.
“An opportunity to collaborate with a Pharma giant in the Regulatory Intelligence space is an absolute privilege and this being initiated with digital automation technology is something we really look forward to as we believe the digital transformation in Life Sciences is the next big thing,” said Suren Dheenadayalan, CEO, Freyr Solutions. “We are highly positive that this partnership will enable the customer to meet the global Regulatory Intelligence requirements and enhance their decision-making in creating meticulous market strategies," added Suren.
Freyr is one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry supporting, Large, Medium, and Small Size Global Life sciences companies (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics) in their entire Regulatory value-chain, ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post- Approval/Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions. Freyr is also expanding its footprint into other key areas like Pharmacovigilance.
Headquartered in New Jersey, USA, Freyr has regional offices across the UK, Germany, France, Switzerland, UAE, Canada, Mexico, Singapore, Malaysia, South Africa, Slovenia, Sri Lanka, Australia, Poland, China, Japan and has a Global Delivery Center in Hyderabad, India.
- 1000+ global customers and growing
- 1300+ in-house Regulatory experts
- 950+ in-country Regulatory affiliates across 120+ countries
- ISO 9001 Certified for strong process and quality management
- ISO 27001 Certified for information security management, state-of-the-art infrastructure